Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
143.1 USD | +1.00% | +4.14% | +8.71% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.71% | 14.26B | |
+10.39% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.87% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-11.04% | 16.99B | |
+41.78% | 12.76B | |
+329.66% | 8.62B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences : Wedbush Adjusts Price Target on Neurocrine Biosciences to $107 From $112, Keeps Outperform Rating